Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer.

Overall survival (OS) and relapse free survival (RFS) were studied in 297 patients according to the presence of insulin-like growth factor 1 receptors (IGF1-R). All the patients were surgically treated for locoregional disease in the same institution from January 1986. The median duration of follow-up was 40 months. RFS was better in patients with IGF1-R in their tumors as assessed by actuarial survival (P = 0.014) as well as Cox analysis (P = 0.016). OS was better in IGF1-R positive tumors studied by actuarial (P = 0.007) as well as Cox analysis (P = 0.010). By Cox analysis the other prognostic factors on RFS were estrogen receptor (P = 0.002), progesterone receptor (P = 0.002), axillary node metastases (P = 0.032), histoprognostic grading (GHP) according to the standard of Scarff and Bloom (P = 0.004), and tumor diameter (P = 0.019). The other prognostic factors on OS (Cox analysis) were estrogen receptor (P = 0.001), axillary node metastases (P = 0.010), GHP (P = 0.009), progesterone receptor (P = 0.012), and tumor diameter (P = 0.007). When combining IGF1-R, GHP, and axillary node metastases, it appeared that IGF1-R, GHP, and axillary node metastases had independent prognostic significance. In this prospective study IGF1-R had a prognostic significance on RFS as well as on OS studied by actuarial as well as Cox analysis.

[1]  R. Furlanetto,et al.  Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. , 1984, Cancer research.

[2]  R. Margolese,et al.  Presence of somatomedin receptors on primary human breast and colon carcinomas. , 1987, Cancer letters.

[3]  J. Bonneterre,et al.  Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. , 1988, Cancer Research.

[4]  A. Stiles,et al.  Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Wilson,et al.  Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. , 1988, Biochemical and biophysical research communications.

[6]  J. Bonneterre,et al.  Characterization of insulin-like growth factor 1 receptors (IGF1-R) in human breast cancer cell lines. , 1989, Bulletin du cancer.

[7]  B. Moats-Staats,et al.  Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. , 1986, The Journal of biological chemistry.

[8]  J. Bonneterre,et al.  Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease. , 1988, European journal of cancer & clinical oncology.

[9]  J. Bonneterre,et al.  Prognostic significance of prolactin receptors in human breast cancer. , 1987, Cancer research.

[10]  Kenneth P. Karey,et al.  Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. , 1988, Cancer research.

[11]  W. Daughaday,et al.  Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. , 1987, The Journal of laboratory and clinical medicine.

[12]  J. Perdue Chemistry, structure, and function of insulin-like growth factors and their receptors: a review. , 1984, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

[13]  J. Bonneterre,et al.  Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer. , 1986, European journal of cancer & clinical oncology.

[14]  R. Furlanetto,et al.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. , 1977, The Journal of clinical investigation.

[15]  D. Yee,et al.  The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. , 1989, Biochemical and biophysical research communications.

[16]  R. Dickson,et al.  Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. , 1987, Endocrine reviews.

[17]  D.,et al.  Regression Models and Life-Tables , 2022 .

[18]  A. N. Corps,et al.  The insulin-like growth factor I content in human milk increases between early and full lactation. , 1988, The Journal of clinical endocrinology and metabolism.

[19]  R. Shiu,et al.  Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. , 1984, Cancer research.

[20]  W. McGuire,et al.  Specific progesterone receptors in human breast cancer , 1975, Steroids.

[21]  J. Foekens,et al.  Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. , 1989, Cancer research.

[22]  R. Sutherland,et al.  HIGH MOLECULAR WEIGHT SOMATOMEDIN-C/IGF-I FROM T47D HUMAN MAMMARY CARCINOMA CELLS: IMMUNOREACTIVITY AND BIOACTIVITY , 1983 .

[23]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[24]  S Friedman,et al.  The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  D. Kaufman,et al.  Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. , 1986, Cancer research.

[26]  E. Froesch,et al.  Pathophysiological and clinical aspects of the insulin-like growth factors. , 1986, Hormone research.

[27]  G. Bell,et al.  Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. , 1987, Endocrinology.

[28]  C. Polychronakos,et al.  Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells. , 1988, Biochemical and biophysical research communications.

[29]  D. Wilson,et al.  Characterization of insulin-like growth factor binding proteins from human breast cancer cells. , 1989, Molecular endocrinology.

[30]  A. Nicolin,et al.  Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro , 1987, Molecular and Cellular Endocrinology.

[31]  A. Koenders,et al.  Standardization of steroid receptor assays in human breast cancer--IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays. , 1986, European journal of cancer & clinical oncology.

[32]  D. Yee,et al.  Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. , 1989, Molecular endocrinology.